Recurrent Pregnancy Loss in Women with Hashimoto's Thyroiditis with Concurrent Non-Endocrine Autoimmune Disorders
Observational
OA: green
CC0
⤵ 1 in-corpus citation
AI-generated summary
Women with Hashimoto's thyroiditis and concurrent non-endocrine autoimmune disorders face a higher risk of recurrent pregnancy loss, although antiphospholipid syndrome explains only a fraction of this rate.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Background: An increased rate of recurrent miscarriage has been described in patients with autoimmune thyroid disease. However, there is a lack of studies that assess the rate of recurrent pregnancy loss (RPL) in patients with Hashimoto's thyroiditis (HT) isolated or with concurrent non-endocrine autoimmune disorders (NEAD). The objective of the study was to assess the rate of RPL in patients with HT isolated or accompanied with non-endocrine autoimmune diseases. Methods: This is a retrospective observational cohort study with a systematic review of the NEAD with concurrent HT in an outpatient Endocrinology Unit at a University Hospital. Among the 3480 consecutively examined women with HT, 87 patients met the criteria of RPL and represented the study group. Sixty-five of them had isolated HT and 22 women had HT+NEAD. Results: The rate of RPL in women with HT was 2.1% versus 5.64% observed in women with HT+NEAD (odds ratio = 2.78 [95% confidence interval 1.70-4.57]; p < 0.0001). On subdivision, this difference was still evident in euthyroid patients (p < 0.0001), while it disappeared in hypothyroid women (p = 0.21). The RPL did not correlate with the autoantibody concentrations nor in women with isolated HT nor in those with HT+NEAD. The presence of antiphospholipid syndrome (APS) explained RPL in 3 out of 22 (14%) patients with HT+NEAD, the remaining being related to different autoimmune disorders. Interestingly, even subtracting the patients with APS, RPL was more frequent in patients with poly-autoimmunity than in patients with isolated HT (p = 0.0013). Conclusions: The co-presence of NEAD is correlated with a higher risk of RPL in women with HT. The association with APS may explain only a fraction of RPL rate in patients with poly-autoimmunity.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
References (48)
- doi:10.1093/hropen/hoy004 via openalex
- doi:10.1111/bjh.14632 via openalex
- doi:10.1007/s12020-015-0671-1 via openalex
- doi:10.1111/j.1365-2249.2011.04419.x via openalex
- W1541384425 via openalex
- doi:10.1186/1741-7015-11-154 via openalex
- doi:10.1016/j.jaut.2011.11.014 via openalex
- doi:10.1016/j.autrev.2014.01.007 via openalex
- doi:10.1111/j.1365-2265.2007.02752.x via openalex
- doi:10.1080/08916930410001705394 via openalex
- doi:10.1111/nyas.13503 via openalex
- doi:10.1016/s2213-8587(17)30402-3 via openalex
- doi:10.1056/nejmra021194 via openalex
- doi:10.1007/s10067-014-2737-5 via openalex
- doi:10.1038/nrendo.2010.46 via openalex
- doi:10.1016/s0015-0282(00)01589-2 via openalex
- W2167806592 via openalex
- doi:10.1038/nrgastro.2013.101 via openalex
- doi:10.1016/j.autrev.2016.09.009 via openalex
- doi:10.1016/j.jri.2009.12.006 via openalex
- doi:10.1007/s00404-004-0706-y via openalex
- doi:10.1111/j.1538-7836.2006.01753.x via openalex
- doi:10.1111/j.1600-0897.2012.01118.x via openalex
- doi:10.1016/j.amjmed.2009.06.030 via openalex
- doi:10.1016/j.clim.2017.04.012 via openalex
- doi:10.1210/jc.2011-1851 via openalex
- doi:10.1016/s0002-9378(12)90830-3 via openalex
- doi:10.1007/s10815-016-0720-6 via openalex
- doi:10.1001/jama.1990.03450110068029 via openalex
- doi:10.1097/mcg.0b013e31827a6f83 via openalex
- doi:10.1016/j.clim.2013.10.001 via openalex
- doi:10.1089/thy.2011.0087 via openalex
- doi:10.3389/fendo.2017.00092 via openalex
- doi:10.1016/j.jaut.2014.01.019 via openalex
- doi:10.1530/eje.0.1500751 via openalex
- doi:10.1016/j.beem.2004.03.007 via openalex
- doi:10.1093/humrep/16.10.2219 via openalex
- doi:10.1136/jcp.2004.021881 via openalex
- doi:10.1210/jc.2009-1719 via openalex
- doi:10.1038/ncpendmet0846 via openalex
- doi:10.1089/thy.2016.0457 via openalex
- doi:10.1080/14397595.2018.1438093 via openalex
- doi:10.1111/j.1365-2265.2010.03974.x via openalex
- doi:10.1111/j.1600-0897.2004.00215.x via openalex
- doi:10.3389/fendo.2017.00138 via openalex
- doi:10.1210/jc.2010-0340 via openalex
- doi:10.3389/fendo.2017.00175 via openalex
- doi:10.1016/j.autrev.2017.07.006 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T05:18:01.733872+00:00
- pubmed
- last seen: 2026-10-08T21:26:25.435920+00:00
License: CC0
· commercial use OK